[1]Patent:WO2014/210354,2014,A1.Locationinpatent:Page/Pagecolumn39;40
[2]JournalofMedicinalChemistry,2016,vol.59,p.9080-9093
1163248-54-1 | (3-Methyl-1h-pyrazol-5-yl)boronic acid | AA000C4H | MFCD14636621
116570-12-8 | 2-(1H-Tetrazol-1-yl)benzoic acid | AA000CQE | MFCD00657953
116834-96-9 | 3-Methyl-1H-pyrazolo[3,4-b]pyridine | AA000D79 | MFCD09607943
117052-19-4 | 1-(5-Chloro-2,3-dimethoxy-phenyl)-ethanone | AA000DJP | MFCD09800420
1172088-56-0 | (5-Methyl-1,3,4-oxadiazol-2-yl)methanamine HCl | AA000DUC | MFCD06738896
117391-52-3 | 3-Amino-3-(4-ethylphenyl)propanoic acid | AA000E52 | MFCD01990387
114561-15-8 | 2(1H)-Quinolinone, 3-(hydroxymethyl)-1-methyl- | AA000EL9 | MFCD06738250
114772-34-8 | 4'-Methylbiphenyl-2-carboxylic acid methyl ester | AA000F4A | MFCD03453661
115-80-0 | Triethyl orthopropionate | AA000FHO | MFCD00009226
1150271-30-9 | 1-(2-(4-Bromophenoxy)ethyl)pyrazole | AA000FNI | MFCD11855961